1606 Corp 最大收入来源是 Chimeric Antigen Receptor Macrophage and Monocyte Cell Therapy,在最近的收益报告中收入为 19,632,000。就地区而言, United States 是 1606 Corp 的主要市场,收入为 19,632,000。
1606 Corp 是否盈利?
不,根据最新的财务报表,1606 Corp 的净损失为 $-1
1606 Corp 有负债吗?
是的,1606 Corp 的负债为 1
1606 Corp 的流通股有多少?
1606 Corp 的总流通股为 58.58
关键数据
前收盘价
$0.001
开盘价
$0.0014
当日区间
$0.001 - $0.0014
52周范围
$0.001 - $0.037
交易量
5.7M
平均成交量
21.4M
股息收益率
--
每股收益(TTM)
-0.02
市值
$677.1K
什么是 CBDW?
1606 Corp. manufactures tobacco products. The company is headquartered in Phoenix, Arizona and currently employs 1 full-time employees. The company went IPO on 2023-01-12. The firm specializes in building and merchandizing AI Chatbots for the cannabidiol (CBD) industry and AI Chatbots for public companies. ChatCBDW chatbot offers CBD and wellness merchants the ability to improve sales by providing product recommendations, track user behavior for inventory management, and ChatCBDW can also provide information on products and education around the clock. ChatCBDW is a proprietary bot fully integrated with ChatGPT, a language model developed by OpenAI. This integration equips ChatCBDW with natural language processing (NLP) and machine learning capabilities, allowing lifelike conversations and intelligent product recommendations. IRChat is a chatbot that is able to go on a public company’s website and pull-down vital information for investors and shareholders. Examples of this vital information include SEC filings, company updates and press releases, and others.